AT376366B - Verfahren zur herstellung eines arzneimittels - Google Patents

Verfahren zur herstellung eines arzneimittels

Info

Publication number
AT376366B
AT376366B AT0172081A AT172081A AT376366B AT 376366 B AT376366 B AT 376366B AT 0172081 A AT0172081 A AT 0172081A AT 172081 A AT172081 A AT 172081A AT 376366 B AT376366 B AT 376366B
Authority
AT
Austria
Prior art keywords
producing
medicinal product
medicinal
product
Prior art date
Application number
AT0172081A
Other languages
English (en)
Other versions
ATA172081A (de
Inventor
Eraldo Borgo
Original Assignee
Made Italiana Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana Srl filed Critical Made Italiana Srl
Publication of ATA172081A publication Critical patent/ATA172081A/de
Application granted granted Critical
Publication of AT376366B publication Critical patent/AT376366B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0172081A 1980-04-18 1981-04-15 Verfahren zur herstellung eines arzneimittels AT376366B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (2)

Publication Number Publication Date
ATA172081A ATA172081A (de) 1984-04-15
AT376366B true AT376366B (de) 1984-11-12

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0172081A AT376366B (de) 1980-04-18 1981-04-15 Verfahren zur herstellung eines arzneimittels

Country Status (15)

Country Link
US (1) US4386077A (de)
AT (1) AT376366B (de)
AU (1) AU544469B2 (de)
BE (1) BE890796A (de)
CH (1) CH652026A5 (de)
DE (1) DE3115080C2 (de)
DK (1) DK173081A (de)
ES (1) ES8207184A1 (de)
FR (1) FR2480603B1 (de)
GB (1) GB2074445B (de)
IN (1) IN156105B (de)
IT (1) IT1207106B (de)
NL (1) NL8101899A (de)
SE (1) SE447449B (de)
ZA (1) ZA812600B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (de) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. Pharmazeutische Zusammenstellung
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
JPH11511732A (ja) * 1995-03-06 1999-10-12 インターニューロン ファーマシューティカルズ，インコーポレーテッド シチコリンを用いる梗塞容積の低減
AU2001247474A1 (en) * 2000-03-16 2001-09-24 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
JPWO2004075905A1 (ja) * 2003-02-26 2006-06-01 協和醗酵工業株式会社 筋肉増強剤および筋肉減衰の予防または治療剤
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
US20090215714A1 (en) * 2004-06-10 2009-08-27 Perry Renshaw Pyrimidines, such as cytidine, in treatments for patients with biopolar disorder
US7947661B2 (en) * 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666748A (en) * 1967-12-18 1972-05-30 Takeda Chemical Industries Ltd Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (de) * 1969-08-04 1973-12-07
JPS4886869A (de) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
FR2480603B1 (fr) 1985-07-12
US4386077A (en) 1983-05-31
AU544469B2 (en) 1985-05-30
ES502080A0 (es) 1982-09-01
ES8207184A1 (es) 1982-09-01
AU6994581A (en) 1981-10-22
NL8101899A (nl) 1981-11-16
SE8102456L (sv) 1981-10-19
DE3115080A1 (de) 1982-02-25
GB2074445B (en) 1983-09-07
ZA812600B (en) 1982-04-28
FR2480603A1 (fr) 1981-10-23
ATA172081A (de) 1984-04-15
CH652026A5 (it) 1985-10-31
SE447449B (sv) 1986-11-17
GB2074445A (en) 1981-11-04
BE890796A (fr) 1982-02-15
IT8048454A0 (it) 1980-04-18
IT1207106B (it) 1989-05-17
DK173081A (da) 1981-10-19
IN156105B (de) 1985-05-18
DE3115080C2 (de) 1986-10-16

Similar Documents

Publication Publication Date Title
AT388849B (de) Verfahren zur herstellung eines diaet-faserproduktes
AT385179B (de) Verfahren und vorrichtung zur herstellung eines zusammengesetzten konfektproduktes
AT369988B (de) Verfahren zur herstellung eines coccidienbekaempfungsmittels
AT369429B (de) Verfahren zur herstellung eines teilreduzierten produktes
AT386744B (de) Verfahren zur herstellung eines wundheilmittels
AT372072B (de) Verfahren zur herstellung eines neuen platinisocitrat-komplexes
AT389273B (de) Verfahren zur herstellung eines behaelters
AT375016B (de) Verfahren zur herstellung eines mundpflegemittels
AT376366B (de) Verfahren zur herstellung eines arzneimittels
AT384905B (de) Verfahren zur herstellung eines kontaktelementes
AT357407B (de) Verfahren zur herstellung eines speckaehnlichen produktes
AT364688B (de) Verfahren zur herstellung eines aromaproduktes
DD132466A1 (de) Verfahren zur herstellung eines vitaminproduktes
AT370286B (de) Verfahren zur herstellung eines medizinischdi[tetischen produktes
ATA499079A (de) Verfahren zur herstellung eines synthetischen crepegarns
AT375381B (de) Verfahren zur herstellung eines kunststoffaufklebeerzeugnisses
AT374342B (de) Verfahren zur herstellung eines suesswarenkauoder -lutschproduktes
AT374365B (de) Verfahren zur herstellung eines pharmazeutischen praeparates
AT379295B (de) Verfahren zur herstellung eines fleischproduktes
ATA51381A (de) Verfahren zur herstellung eines 1-/p-chlorbenzoyl)-5-methoxy-2-methyl-indol-3-y -essigsaeure nethaltendes arzneimittels
AT376966B (de) Verfahren zur herstellung eines furanderivats
AT366558B (de) Verfahren zur herstellung eines neuen fleischproduktes
ATA223188A (de) Verfahren zur herstellung eines arzneimittels
AT371876B (de) Verfahren zur herstellung eines bauwerkes
ATA93982A (de) Verfahren zur herstellung eines 3-vinyl-cephalosporins

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee